Meridian Bioscience, Inc. announced that Andy Kitzmiller joined Meridian Bioscience as Chief Financial Officer, reporting directly to CEO Jack Kenny. He will oversee the global finance organization and financial activities, including accounting and controllership, financial planning and analysis, tax, internal audit, and treasury. Mr. Kitzmiller joins Meridian from Hillenbrand, Inc., where he was Vice President, Chief Accounting Officer, and Corporate Controller.
Meridian Bioscience, Inc.
Equities
VIVO
US5895841014
Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | |
---|---|---|
-4.86% | 181B | |
+3.02% | 112B | |
-2.56% | 67.92B | |
+4.62% | 50.1B | |
+8.07% | 44.27B | |
+9.39% | 40.41B | |
+25.53% | 31.95B | |
-0.21% | 25.82B | |
+17.27% | 25.29B |